147 related articles for article (PubMed ID: 26089623)
21. Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome.
Mansour A; Hashemi Taheri AP; Moradi B; Mohajeri-Tehrani MR; Qorbani M; Ghorbani Pashakolaee S; Sanginabadi M; Sajjadi-Jazi SM
BMC Endocr Disord; 2022 Dec; 22(1):298. PubMed ID: 36456925
[TBL] [Abstract][Full Text] [Related]
22. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.
Al-Ojaimi EH
Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594
[TBL] [Abstract][Full Text] [Related]
23. Source localization of androgen excess in adolescent girls.
Ibáñez L; Potau N; Zampolli M; Prat N; Gussinyé M; Saenger P; Vicens-Calvet E; Carrascosa A
J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
[TBL] [Abstract][Full Text] [Related]
24. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
25. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
26. A Model Combining Testosterone, Androstenedione and Free Testosterone Index Improved the Diagnostic Efficiency of Polycystic Ovary Syndrome.
Yi W; Zhang M; Yuan X; Shi L; Yuan X; Sun M; Liu J; Cai H; Lv Z
Endocr Pract; 2023 Aug; 29(8):629-636. PubMed ID: 37225042
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
[TBL] [Abstract][Full Text] [Related]
28. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH
Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339
[TBL] [Abstract][Full Text] [Related]
29. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
30. [LH-FSH ratio and Polycystic Ovary Syndrome: A forgotten test?].
Saucedo de la Llata E; Moraga-Sánchez MR; Romeu-Sarrió A; Carmona-Ruiz IO
Ginecol Obstet Mex; 2016 Feb; 84(2):84-94. PubMed ID: 27290835
[TBL] [Abstract][Full Text] [Related]
31. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
[TBL] [Abstract][Full Text] [Related]
33. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
34. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E
Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068
[TBL] [Abstract][Full Text] [Related]
36. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
37. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.
Chun S
Clin Exp Reprod Med; 2014 Jun; 41(2):86-91. PubMed ID: 25045633
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent.
Seyam E; Hefzy E
Gynecol Endocrinol; 2018 Jun; 34(6):481-488. PubMed ID: 29254383
[TBL] [Abstract][Full Text] [Related]
39. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.
Loverro G; Vicino M; Lorusso F; Vimercati A; Greco P; Selvaggi L
Gynecol Endocrinol; 2001 Apr; 15(2):142-9. PubMed ID: 11379011
[TBL] [Abstract][Full Text] [Related]
40. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Pangaribuan B; Yusuf I; Mansyur M; Wijaya A
Ther Adv Endocrinol Metab; 2011 Dec; 2(6):235-45. PubMed ID: 23148188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
